Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
World Journal of Surgery
Published in: World Journal of Surgery 3/2015

01-03-2015

Endoscopic Treatments for Dysplastic Barrett’s Esophagus: Resection, Ablation, What Else?

Authors: Charumathi Raghu Subramanian, George Triadafilopoulos

Published in: World Journal of Surgery | Issue 3/2015

Login to get access

Abstract

Background

Endoscopic eradication therapy for dysplastic Barrett’s esophagus (BE) comprises resection and mucosal ablation techniques. Over the years, these techniques have been tried with success, not only for dysplastic Barrett’s epithelium but also for non-dysplastic Barrett’s epithelium and early adenocarcinoma. Endoscopic resection is usually carried out for visible lesions, either as endoscopic mucosal resection (EMR), which is practiced widely in Western countries, or as endoscopic submucosal dissection, which is more popular in Japan and throughout Asia. Among ablative techniques are photodynamic therapy, cryotherapy, and radiofrequency ablation (RFA).

Methods

We reviewed the published evidence pertaining to endoscopic treatments of dysplastic BE, with emphasis on the various resection and ablative techniques, their safety, efficacy, durability of effect, and tolerability.

Results

Both resection and ablation procedures performed endoscopically have been proved effective, and safe for treating dysplastic BE and early adenocarcinoma. Among the ablative techniques, RFA has shown to be more effective and safe, and is preferred for most cases.

Conclusions

Endoscopic therapies have revolutionized the treatment of BE and have minimized the need for surgical intervention in many patients. Concomitant treatment of acid reflux with proton pump inhibitors and continuous surveillance are essential. Combination techniques such as EMR followed by RFA may be also considered in some cases.
Literature
1.
Akiyama J, Triadafilopoulos G (2010) Endoscopic ablation therapy of Barrett’s esophagus. Minerva Gastroenterol Dietol 56:405–420PubMed
2.
Arora G, Basra S, Roorda AK et al (2009) Radiofrequency ablation of Barrett’s esophagus. Eur Surg 41:19–25CrossRef
3.
ASGE Standards of Practice Committee (2012) The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc 76:1087–1094CrossRef
4.
Mino-Kenudson M, Hull MJ, Brown I et al (2007) EMR for Barrett’s esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastrointest Endosc 66(4):660–666 quiz 767, 769CrossRefPubMed
5.
Sharma P, Dent J, Armstrong D et al (2006) The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 131:1392–1399CrossRefPubMed
6.
Fleischer DE, Odze R, Overholt BF et al (2010) The case for endoscopic reatment of non-dysplastic and low-grade dysplastic Barrett’s esophagus. Dig Dis Sci 55:1918–1931CrossRefPubMed
7.
Pouw RE, van Vilsteren FG, Peters FP et al (2011) Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett’s neoplasia. Gastrointest Endosc 74:35–43CrossRefPubMed
8.
Pouw RE, Bergman JJ (2013) Radiofrequency ablation for Barrett’s esophagus, for whom and by whom? Clin Gastroenterol Hepatol 11:1256–1258CrossRefPubMed
9.
10.
Ackroyd R, Brown NJ, Davis MF et al (2000) Photodynamic therapy for dysplastic Barrett’s oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut 47:612–617CrossRefPubMedCentralPubMed
11.
Overholt BF, Lightdale CJ, Wang KW et al (2005) Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62:488–498CrossRefPubMed
12.
Gray J, Fullarton GM (2013) Long term efficacy of photodynamic therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett’s oesophagus. Photodiagn Photodyn Ther 10:561–565CrossRef
13.
Ertan A, Zaheer I, Correa AM et al (2013) Photodynamic therapy vs radiofrequency ablation for Barrett’s dysplasia: efficacy, safety and cost-comparison. World J Gastroenterol 19:7106–7113CrossRefPubMedCentralPubMed
14.
Wang KK, Kim JY (2003) Photodynamic therapy in Barrett’s esophagus. Gastrointest Endosc Clin North Am 13:483–489CrossRef
15.
Dunn JM, Mackenzie GD, Banks MR et al (2013) A randomised controlled trial of ALA vs photofrin photodynamic therapy for high-grade dysplasia arising in Barrett’s oesophagus. Lasers Med Sci 28:707–715CrossRefPubMed
16.
Ban S, Mino M, Nishioka NS et al (2004) Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett’s esophagus. Am J Surg Pathol 28:1466–1473CrossRefPubMed
17.
Sharma VK, Wang KK, Overholt BF et al (2007) Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett’s esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 65:185–195CrossRefPubMed
18.
Fleischer DE, Overholt BF, Sharma VK et al (2008) Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 68:867–876CrossRefPubMed
19.
Fleischer DE, Overholt BF, Sharma VK et al (2010) Endoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy 42:781–789CrossRefPubMed
20.
Shaheen NJ, Sharma P, Overholt BF et al (2009) Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 360:2277–2288CrossRefPubMed
21.
Shaheen NJ, Overholt BF, Sampliner RE et al (2011) Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology 141:460–468CrossRefPubMedCentralPubMed
22.
Phoa KY, van Vilsteren FG, Pouw RE et al (2013) Radiofrequency ablation in Barrett’s esophagus with confirmed low-grade dysplasia: interim results of a European multicenter randomized controlled trial (SURF). Gastroenterology 144(Suppl 1):S–187
23.
Chadwick G, Groene O, Markar SR et al (2014) Systematic review comparing radiofrequency ablation and complete endoscopic resection in treating dysplastic Barrett’s esophagus: a critical assessment of histologic outcomes and adverse events. Gastrointest Endosc 79:718–731CrossRefPubMed
24.
Bulsiewicz WJ, Kim HP, Dellon ES et al (2013) Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett’s esophagus. Clin Gastroenterol Hepatol 11:636–642CrossRefPubMedCentralPubMed
25.
Gupta M, Iyer PG, Lutzke L et al (2013) Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett’s esophagus: results from a US multicenter consortium. Gastroenterology 145:79–86CrossRefPubMedCentralPubMed
26.
Korst RJ, Santana-Joseph S, Rutledge JR et al (2013) Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett’s esophagus. J Thorac Cardiovasc Surg 145:1529–1534CrossRefPubMed
27.
Orman ES, Kim HP, Bulsiewicz WJ et al (2013) Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett’s esophagus with radiofrequency ablation. Am J Gastroenterol 108:187–195 quiz 196CrossRefPubMed
28.
Korst RJ, Santana-Joseph S, Rutledge JR et al (2011) Effect of hiatal hernia size and columnar segment length on the success of radiofrequency ablation for Barrett’s esophagus: a single center, phase II clinical trial. J Thorac Cardiovasc Surg 142:1168–1173CrossRefPubMed
29.
van Vilsteren FG, Alvarez Herrero L, Pouw RE et al (2013) Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett’s esophagus with early neoplasia: a prospective multicenter study. Endoscopy 45:516–525CrossRefPubMed
30.
Greenwald BD, Dumot JA (2011) Cryotherapy for Barrett’s esophagus and esophageal cancer. Current Opin Gastroenterol 27:363–367CrossRef
31.
Shaheen L, Bruce J, Greenwald D et al (2010) Safety and efficacy of endoscopic spray cryotherapy for Barrett’s esophagus with high-grade dysplasia. Gastrointest Endosc 71:680–685CrossRefPubMedCentralPubMed
32.
Gosain S, Mercer K, Twaddell WS et al (2013) Liquid nitrogen spray cryotherapy in Barrett’s esophagus with high-grade dysplasia: long-term results. Gastrointest Endosc 78:260–265CrossRefPubMed
33.
Halsey KD, Chang JW, Waldt A et al (2011) Recurrent disease following endoscopic ablation of Barrett’s high-grade dysplasia with spray cryotherapy. Endoscopy 43:844–848CrossRefPubMed
34.
Inoue H, Fukami N, Yoshida T et al (2002) Endoscopic mucosal resection for esophageal and gastric cancers. J Gastroenterol Hepatol 17:382–388CrossRefPubMed
35.
May A, Gossner L, Behrens A et al (2003) A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc 58:167–175CrossRefPubMed
36.
Alvarez Herrero L, Pouw RE, van Vilsteren FGI et al (2011) Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett’s esophagus. Endoscopy 43:177–183CrossRefPubMed
37.
Pouw RE, van Vilsteren FGI, Peters FP et al (2011) Randomized trial on endoscopic resection—cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett’s neoplasia. Gastrointest Endosc 74:35–43CrossRefPubMed
38.
Koike T, Nakagawa K, Iijima K et al (2013) Endoscopic resection (endoscopic submucosal dissection/endoscopic mucosal resection) for superficial Barrett’s esophageal cancer. Dig Endosc 25(Suppl 1):20–28CrossRefPubMed
39.
Cao Y, Liao C, Tan A et al (2009) Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 41:751–757CrossRefPubMed
40.
Barret M, Pratico CA, Beuvon F et al (2013) Esophageal circumferential en bloc endoscopic submucosal dissection: assessment of a new technique. Surg Laparosc Endosc Percutan Tech 23:e182–e187CrossRefPubMed
41.
Wen J, Yang Y, Liu Q et al (2014) Preventing stricture formation by covered esophageal stent placement after endoscopic submucosal dissection for early esophageal cancer. Dig Dis Sci 59:658–663CrossRefPubMed
42.
Seewald S, Ang TL, Gotoda T et al (2008) Total endoscopic resection of Barrett esophagus. Endoscopy 40:1016–1020CrossRefPubMed
43.
Pouw RE, Seewald S, Gondrie JJ et al (2010) Stepwise radical endoscopic resection for eradication of Barrett’s oesophagus with early neoplasia in a cohort of 169 patients. Gut 59:1169–1177CrossRefPubMed
44.
Chung A, Bourke MJ, Hourigan LF et al (2011) Complete Barrett’s excision by stepwise endoscopic resection in short-segment disease: long term outcomes and predictors of stricture. Endoscopy 43:1025–1032CrossRefPubMed
45.
Ezoe Y, Muto M, Horimatsu T et al (2011) Efficacy of preventive endoscopic balloon dilation for esophageal stricture after endoscopic resection. J Clin Gastroenterol 45:222–227CrossRefPubMed
46.
Manner H, Pech O, Heldmann Y et al (2014) Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk Sm1 invasion. Clin Gastroenterol Hepatol 11:630–635 quiz e45CrossRef
47.
Chennat J, Konda VJA, Ross AS et al (2009) Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma—an American single-center experience. Am J Gastroenterol 104:2684–2692CrossRefPubMed
48.
Pech O, May A, Manner H et al (2013) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146:652–660CrossRefPubMed
49.
50.
Pech O, Behrens A, May A et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 57:1200–1206CrossRefPubMed
51.
Pacifico RJ, Wang KK, Wongkeesong L-M et al (2003) Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett’s esophagus. Clin Gastroenterol Hepatol 1:252–257CrossRefPubMed
52.
Pouw RE, Wirths K, Eisendrath P et al (2010) Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol 8:23–29CrossRefPubMed
53.
Haidry RJ, Dunn JM, Butt MA et al (2013) Radiofrequency ablation and endoscopic mucosal resection for dysplastic Barrett’s esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry. Gastroenterology 145:87–95CrossRefPubMed
54.
Kim HP, Bulsiewicz WJ, Cotton CC et al (2012) Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett’s esophagus with advanced neoplasia. Gastrointest Endosc 76:733–739CrossRefPubMedCentralPubMed
Metadata
Title
Endoscopic Treatments for Dysplastic Barrett’s Esophagus: Resection, Ablation, What Else?
Authors
Charumathi Raghu Subramanian
George Triadafilopoulos
Publication date
01-03-2015
Publisher
Springer US
Published in
World Journal of Surgery / Issue 3/2015
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-014-2636-6

Other articles of this Issue 3/2015

World Journal of Surgery 3/2015 Go to the issue

Original Scientific Report

Surgical Treatment of Incidental Gallbladder Cancer Discovered During or Following Laparoscopic Cholecystectomy

Original Scientific Report

The Modern Surgeon and Competency Assessment: Are the Workplace-Based Assessments Evidence-Based?

Brief Original Scientific Report

Use of a 90° Drill and Screwdriver for Rib Fracture Stabilization

Reply, Letter to the Editor

Preoperative Biliary Drainage of Severely Jaundiced Patients Increases Morbidity of Pancreaticoduodenectomy: Reply

Original Scientific Report

Pedestrian Injuries-Related Deaths: A Global Evaluation

OriginalPaper

Biomarkers for Dysplastic Barrett’s: Ready for Prime Time?